News

Targeted Treatment of Rare Childhood Leukemia

Juvenile myelomonocytic leukemia (JMML) is a rare but aggressive childhood leukemia. While hematopoietic stem cell transplantation is curative for some patients, approximately half of all patients will still have their leukemia return following a transplant. Recent studies have identified that the

New Pediatric Cancer Marker, New Hope for a Treatment Target

Researchers recently identified a universal, essential biomarker for the childhood cancer neuroblastoma – and the biomarker could be a potential new target for treatment. Neuroblastoma accounts for 15% of all pediatric cancer deaths and is the most common source of childhood tumors outside of brain

Can a New Drug Candidate Cure Pancreatic Cancer?

UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition. The new drug candidate permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for

Targeted Treatment of Rare Childhood Leukemia

Juvenile myelomonocytic leukemia (JMML) is a rare but aggressive childhood leukemia. While hematopoietic stem cell transplantation is curative for some patients, approximately half of all patients see their leukemia return following a transplant. Recent studies have identified that the number of

Can AI Help Doctors Find Cancer Faster by Reviewing Records?

A form of artificial intelligence called large language modeling (LLM), the same technology behind ChatGPT, could someday improve liver cancer care by extracting important data from medical charts much faster than humans, a recent UCSF study found. LLMs use deep learning and large data sets to

New Walnut Creek Cancer Center Brings Specialty Care Close to Home

The UCSF Health-John Muir Health Jean and Ken Hofmann Cancer Center at the Behring Pavilion opened today, bringing a full spectrum of leading-edge cancer care close to home for people in the East Bay and surrounding areas. The state-of-the art center is an important step in UCSF Health’s vision of

UCSF Tops Public Universities in NIH Research Funding in 2023

It is the 17th year in a row that UCSF has earned this distinction among public institutions. Postdoctoral scholar Oscar Campos, PhD, works in the Lim Lab at UCSF. Photo by Noah Berger “Support from the NIH enables our researchers to test their boldest ideas for advancing science, medicine and